Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37 member A14, pseudogene (LRRC37A14P)
- Target
- LRRC37A14P
- Molecular classification
- Pseudogene, Other (non-coding RNA, since some pseudogenes may be transcribed without encoding a functional protein)
01
Overview
Leucine rich repeat containing 37 member A14, pseudogene (LRRC37A14P), is a processed pseudogene locus. Like other pseudogenes, it is a segment of genomic DNA resembling a protein-coding gene but generally non-functional due to disabling mutations and a lack of ability to produce a functional protein. The biological function for this locus is not established, and there is no known pathological or pharmacological relevance. Pseudogenes can sometimes influence gene expression, but there is no evidence for such a role for LRRC37A14P specifically. Key context: - Pseudogenes may complicate genetic studies because of their sequence similarity to functional genes, but by definition and current knowledge, LRRC37A14P does not encode a functional protein and is not therapeutically targeted. - There are no drugs or disease associations, and it is not used as a biomarker. Any structural similarity to drug targets within the leucine-rich repeat family does not confer functionality or targetability on this specific locus. Summary: LRRC37A14P is a processed pseudogene, not a receptor, enzyme, or other recognized drug target. It is not functionally characterized and has no established therapeutic relevance.
- Other names
- LRRC37A14P
02
Mechanism of action
None
03
Biological functions
None established for LRRC37A14P itselfOther pseudogenes (in general, not specifically LRRC37A14P) can sometimes modulate gene expression via regulatory RNAs, but there is no evidence in the cited data for LRRC37A14P to have such a role
04
Disease associations
None demonstrated for LRRC37A14P itselfPseudogenes as a class can sometimes be markers or have indirect roles in disease via RNA-level regulation, but no primary literature supports this for LRRC37A14P specifically
05
Safety considerations
None, as this is not a functional or druggable target
Beyond the preview
Go deeper on Leucine rich repeat containing 37 member A14, pseudogene (LRRC37A14P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leucine rich repeat containing 37 member A14, pseudogene (LRRC37A14P).